Eftersom både NSAID, insulin og rosiglitazon er associeret med væskeretention, kan samtidig administration forhøje risikoen for ødem.
Since NSAIDs, insulin and rosiglitazone are all associated with fluid retention, concomitant administration may increase the risk of oedema.